📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A public-private partnership to unlock the untargeted kinome. (2013)

First Author: Knapp S

Attributed to: Innovative targets for circadian drug discovery: REV-ERBalpha and RORalpha funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nchembio.1113

PubMed Identifier: 23238671

Publication URI: http://europepmc.org/abstract/MED/23238671

Type: Journal Article/Review

Volume: 9

Parent Publication: Nature chemical biology

Issue: 1

ISSN: 1552-4450